David OToole Net Worth - Insider Trades and Bio as of Jun 20, 2026

RCELAVITA Medical, Inc.SEC CIK: 0001491140

Estimated Net Worth

$3.07 Million

Last Updated: May 19, 2026 11:38 PM EST

Transaction Summary

Total Transactions77

Buy-Sell Ratio8.00

Buy Transactions40

Sell Transactions5

Transaction Volume

Total Volume$628.44K

Net Volume$775.50K

Buy Volume$701.97K

Sell Volume-$73.53K

Trade Analysis

AVG Trade Size-$1.24K

Largest Trade$89.64K

Most Active MonthJan

Most Active Year2023

Trading Sentiment

OverallBullish

Recent TradeBuying

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

David D O'Toole has an estimated net worth of $3.07 Million. This is based on reported shares across multiple companies, which include , OPIANT PHARMACEUTICALS, INC., MEDICINOVA INC, Capnia, Inc., AVITA Medical, Inc., and RESPONSE GENETICS INC.

2023 was David D O'Toole's most active year for acquiring shares with 19 total transactions. David D O'Toole's most active month to acquire stocks was the month of July. 2023 was David D O'Toole's most active year for disposing of shares, totalling 9 transactions. David D O'Toole's most active month to dispose stocks was the month of February. 2018 saw David D O'Toole paying a total of $106,086.00 for 19,215 shares, this is the most they've acquired in one year. In 2023 David D O'Toole cashed out on 90,804 shares for a total of $776,623.66, their largest year based on trade value.

Holdings & Transactions

RCELavita medical, inc.

CFO

Updated: Mar 11, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	1.80K	$4.78	$8.60K	Mar 11, 2026	141.93K	Purchase	—	Mar 11	View
From 4	0.02	3.00K	$4.15	$12.45K	Feb 23, 2026	140.13K	Purchase	—	Feb 19	View
From 4	8.24	260.98K	—	—	Feb 19, 2026	292.64K	Grant	—	Feb 18	View
From 4	0.07	2.00K	$4.52	$9.04K	Aug 26, 2025	31.66K	Purchase	—	Aug 26	View
From 4	0.07	2.00K	$4.81	$9.62K	Aug 12, 2025	29.66K	Purchase	—	Aug 12	View
From 4	0.07	1.92K	$4.78	$9.19K	Jun 02, 2025	27.66K	Grant	—	May 30	View
From 4	0.04	1.00K	$9.90	$9.90K	Feb 20, 2025	25.73K	Purchase	—	Feb 20	View
From 4	0.04	1.00K	$10.25	$10.25K	Feb 19, 2025	24.73K	Purchase	—	Feb 19	View
From 4	—	150.00K	—	—	Jan 22, 2025	150.00K	Grant	—	Jan 21	View
From 4	0.08	1.76K	$10.40	$18.30K	Dec 05, 2024	23.73K	Purchase	—	Nov 29 - 05	View
From 4	0.17	3.24K	$8.39	$27.20K	Jun 03, 2024	21.97K	Purchase	—	May 30 - 31	View
From 4	0.07	1.25K	$17.39	$21.74K	Feb 28, 2024	18.73K	Purchase	—	Feb 28	View
From 4	—	125.00K	—	—	Jan 05, 2024	125.00K	Grant	—	Jan 03	View
From 4	0.06	950.00	$12.45	$11.83K	Dec 12, 2023	17.48K	Purchase	—	Dec 12	View
From 4	0.10	1.53K	$9.59	$14.71K	Dec 04, 2023	16.53K	Purchase	—	Nov 30 - 01	View
From 4	0.15	2.00K	$10.28	$20.56K	Nov 21, 2023	15.00K	Purchase	—	Nov 21	View
From 4	0.18	2.00K	$12.30	$24.60K	Nov 16, 2023	13.00K	Purchase	—	Nov 15 - 16	View
From 4	0.22	2.00K	$13.07	$26.13K	Nov 15, 2023	11.00K	Purchase	—	Nov 14 - 15	View
From 4	0.29	2.00K	$17.06	$34.11K	Aug 16, 2023	9.00K	Purchase	—	Aug 16	View
From 4	2.50	5.00K	$17.93	$89.64K	Aug 15, 2023	7.00K	Purchase	—	Aug 15	View
From 4	1.00	1.00K	$16.15	$16.15K	Jun 21, 2023	2.00K	Purchase	—	Jun 20	View
From 4	—	150.00K	—	—	Jun 16, 2023	150.00K	Grant	—	Jun 15	View
From 3	—	—	—	—	Jun 16, 2023	1.00K	—	—	—	View

opiant pharmaceuticals, inc.

Chief Financial Officer Officer

Updated: Mar 03, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	86.25K	$20.00	-$724.96K	Mar 03, 2023	—	Disposition	—	Mar 02	View
From 4	-0.02	541.00	$20.26	-$10.96K	Jan 31, 2023	34.25K	Sale	—	Jan 27	View
From 4	-0.01	415.00	$20.20	-$8.38K	Jan 09, 2023	34.79K	Sale	—	Jan 09	View
From 4	-0.04	1.60K	$20.20	-$32.32K	Jan 05, 2023	35.20K	Sale	—	Jan 05	View
From 4	-0.02	779.00	$11.10	-$8.65K	Jul 15, 2022	36.80K	Sale	—	Jul 14	View
From 4	0.06	2.00K	—	—	Jun 29, 2022	37.58K	Grant	—	Jun 27	View
From 4	-0.01	432.00	$30.60	-$13.22K	Jan 12, 2022	35.58K	Sale	—	Jan 10	View
From 4	0.50	12.00K	—	—	Jan 05, 2022	36.02K	Grant	—	Jan 04	View
From 4	0.01	200.00	$19.12	$3.82K	Sep 15, 2021	24.02K	Purchase	—	Sep 14	View
From 4	0.03	600.00	$15.38	$9.23K	Aug 16, 2021	23.82K	Purchase	—	Aug 16	View
From 4	1.21	18.60K	—	—	Jan 27, 2021	33.97K	Grant	—	Jan 26	View
From 4	0.07	1.00K	$8.74	$8.74K	Jun 11, 2020	15.37K	Purchase	—	Jun 11	View
From 4	0.07	1.00K	$11.00	$11.00K	May 26, 2020	14.37K	Purchase	—	May 26	View
From 4	1.35	12.40K	—	—	Jan 09, 2020	21.62K	Grant	—	Jan 07	View
From 4	0.01	100.00	$13.22	$1.32K	Nov 26, 2019	9.22K	Purchase	—	Nov 26	View
From 4	0.14	1.10K	$14.92	$16.41K	Nov 15, 2019	9.12K	Purchase	—	Nov 15	View
From 4	0.14	1.00K	$15.20	$15.20K	Aug 15, 2019	8.02K	Purchase	—	Aug 15	View
From 4	0.17	1.00K	$15.46	$15.46K	Aug 13, 2019	7.02K	Purchase	—	Aug 13	View
From 4	—	33.00K	—	—	Jan 04, 2019	33.00K	Grant	—	Jan 03	View
From 4	0.20	1.01K	$15.40	$15.64K	Aug 14, 2018	6.02K	Purchase	—	Aug 14	View
From 4	0.67	2.00K	$16.95	$33.90K	May 16, 2018	5.00K	Purchase	—	May 16	View
From 4	—	3.00K	$18.85	$56.55K	May 14, 2018	3.00K	Purchase	—	May 11	View
From 4	—	13.20K	—	—	Jan 08, 2018	13.20K	Grant	—	Jan 04	View
From 4	—	150.00K	—	—	Sep 14, 2017	150.00K	Grant	—	Sep 12	View
From 3	—	—	—	—	Sep 12, 2017	—	—	—	—	View

SLNOcapnia, inc.

Updated: Apr 24, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	354.94K	—	—	Apr 24, 2017	354.95K	Grant	—	Apr 19	View
From 4	0.05	2.00K	$1.01	$2.02K	Aug 19, 2016	44.75K	Purchase	—	Aug 18	View
From 4	0.31	10.00K	$0.92	$9.24K	Aug 18, 2016	42.75K	Purchase	—	Aug 17	View
From 4	—	90.84K	—	—	Jun 10, 2016	90.84K	Grant	—	Jun 08	View
From 4	0.18	5.00K	$1.16	$5.78K	May 16, 2016	32.75K	Purchase	—	May 12	View
From 4	—	60.00K	—	—	Jan 11, 2016	60.00K	Grant	—	Jan 10	View
From 4	0.22	5.00K	$1.79	$8.95K	Nov 17, 2015	27.75K	Purchase	—	Nov 17	View
From 4	0.49	7.50K	$2.38	$17.89K	Sep 14, 2015	22.75K	Purchase	—	Sep 14	View
From 4	1.90	10.00K	$1.78	$17.80K	Aug 12, 2015	15.25K	Purchase	—	Aug 11	View
From 4	—	30.00K	—	—	May 19, 2015	30.00K	Grant	—	May 15	View
From 4	—	5.25K	$6.23	$32.71K	Mar 16, 2015	5.25K	Purchase	—	Mar 13	View
From 4	—	32.44K	—	—	Jan 13, 2015	32.44K	Grant	—	Jan 11	View
From 4	—	129.77K	—	—	Nov 14, 2014	129.77K	Grant	—	Nov 12	View
From 3	—	—	—	—	Nov 12, 2014	—	—	—	—	View

codexis inc

SVP & Chief Financial Officer Officer

Updated: Sep 06, 2013

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.04	4.70K	$1.76	-$8.27K	Sep 06, 2013	110.69K	Tax	—	Sep 04	View
From 4	0.09	10.00K	$2.02	$20.22K	Mar 05, 2013	115.38K	Purchase	—	Mar 04	View
From 4	2.02	121.41K	—	—	Jan 28, 2013	181.41K	Grant	—	Jan 24	View
From 4	0.09	5.00K	$2.20	$11.00K	Nov 14, 2012	60.00K	Purchase	—	Nov 12	View
From 4	0.10	5.00K	$2.78	$13.88K	Sep 14, 2012	55.00K	Purchase	—	Sep 13 - 14	View
From 4	—	250.00K	—	—	Sep 12, 2012	250.00K	Grant	—	Sep 10	View
From 3	—	—	—	—	Sep 12, 2012	—	—	—	—	View

MNOVmedicinova inc

Updated: May 30, 2012VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	5.00K	$1.78	$8.90K	May 30, 2012	5.00K	Purchase	—	May 29	View
From 4	—	15.00K	—	—	Apr 12, 2012	15.00K	Grant	—	Apr 10	View
From 3	—	—	—	—	Apr 12, 2012	—	—	—	—	View

response genetics inc

VP and Chief Financial Officer Officer

Updated: Feb 06, 2012

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	1.00K	$1.50	$1.50K	Feb 06, 2012	1.00K	Purchase	—	Feb 02	View
From 4	—	30.00K	—	—	Dec 16, 2011	30.00K	Grant	—	Dec 14	View
From 4	—	30.00K	—	—	Apr 14, 2011	30.00K	Grant	—	Apr 12	View
From 4	—	100.00K	—	—	May 05, 2010	100.00K	Grant	—	May 04	View
From 3	—	—	—	—	May 05, 2010	3.50K	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions